Breaking News Instant updates and real-time market news.

AAPL

Apple

$188.78

-2.33 (-1.22%)

, V

Visa

$153.07

0.07 (0.05%)

07:44
03/26/19
03/26
07:44
03/26/19
07:44

Apple Card 'a slight negative' for Visa, says Wedbush

Wedbush analyst Moshe Katri believes Apple's announcement of a physical Apple card is a "slight negative" for Outperform rated Visa (V) and a "slight positive" for Outperform rated MasterCard (MA), assuming it gains traction. The physical Apple card is a partnership with Goldman Sachs (GS) and Mastercard.

AAPL

Apple

$188.78

-2.33 (-1.22%)

V

Visa

$153.07

0.07 (0.05%)

MA

MasterCard

$230.43

-0.34 (-0.15%)

GS

Goldman Sachs

$188.52

-0.05 (-0.03%)

  • 15

    Apr

  • 03

    Jun

  • 25

    Jun

AAPL Apple
$188.78

-2.33 (-1.22%)

03/26/19
KEYB
03/26/19
NO CHANGE
KEYB
Apple straying further from iPhone-linked services, says KeyBanc
KeyBanc analyst Andy Hargreaves notes that Apple has introduced a new TV app, Apple-branded subscriptions in video, gaming, and news, and a new credit card. Each of these services strays further from the iPhone-linked services that have been the primary drivers of Apple's Services segment revenue growth to date, he notes. While Apple's strong brand and user affinity should drive modest volume to each, the analyst sees limited advantages versus existing competition and relatively limited opportunities for significant impact to long-term profits.
03/26/19
MSCO
03/26/19
NO CHANGE
MSCO
Apple Arcade doesn't pose major threat to game makers, says Morgan Stanley
After Apple (AAPL) announced Arcade, a subscription service for mobile games, Morgan Stanley Brian Nowak said the service does not currently pose a major competitive threat to large game publishers Activision Blizzard (ATVI), Electronic Arts (EA) or Take-Two (TTWO). Apple's service doesn't include AAA quality content substitutable for their key franchises and didn't disclose plans to create its own first-party content, noted Nowak, who said that Apple could potentially be a direct competitor to mobile-focused Zynga (ZNGA). However, the overlap is limited by the fact that Zynga focuses exclusively on free-to-play, Nowak added.
03/26/19
COWN
03/26/19
NO CHANGE
Target $220
COWN
Outperform
Apple event had little 'steak,' but did have 'sizzle,' says Cowen
Cowen analyst Krish Sankar told investors in a research note that Apple's "It's Show Time" event had "sizzle," but little "steak." He believes Services is a long-term investable theme, and says the event that introduced the Apple News+, Arcade and TV+ subscription offerings suggest a differentiated but gradual approach to establishing future growth vectors. While he says market reactions to the event could be due to the "thin" details on the TV+, he sees perspectives continuing to shift positively as Services grows further.
03/26/19
WEDB
03/26/19
NO CHANGE
Target $215
WEDB
Outperform
Success of AppleTV+ will play 'vital role' in services growth, says Wedbush
Wedbush analyst Daniel Ives believes Apple's goal with its streaming service is to be a major distribution platform for content and with 1.4B active iOS devices worldwide, with the theme of family and safer viewing platform, the company is trying to differentiate itself versus competitors and "flex its Apple brand muscles" to get more consumers on this "trustworthy" platform. The analyst argues that Apple needs to "tiptoe into this major strategic initiative" as the success on this front will play a vital role in the services growth for years to come. Ives continues to believe the company has the opportunity of capturing 100M consumers on this streaming content service over the next 3-5 years with this" major, potentially game changing content distribution service." He reiterates an Outperform rating and a $215 price target on the shares.
V Visa
$153.07

0.07 (0.05%)

03/14/19
WEDB
03/14/19
NO CHANGE
Target $162
WEDB
Outperform
Visa price target raised to $162 from $150 at Wedbush
Wedbush analyst Moshe Katri raised his price target for Visa to $162 from $150 pointing to a host of growth/scale catalysts, including the disintermediation of cash/checks by electronic payments, networks' increased dominance in the payments' ecosystem, incremental revenue opportunities from European regulations, incremental volume from hyper-growth mobile payments, ACH-based revenue growth opportunities, ongoing revenue/cost synergies contributions from VE and ongoing traction in B2B. The analyst reiterates an Outperform rating on the shares.
03/19/19
DADA
03/19/19
NO CHANGE
Target $160
DADA
Buy
Euronet price target raised to $160 from $158 at DA Davidson
DA Davidson analyst Peter Heckmann raised his price target on Euronet (EEFT) to $160 and kept his Buy rating, updating his model for its convertible debt issuance last week intended to reduce its higher interest bearing debt. The analyst also points to the company's "modest improvement in the FX basket" over the past few weeks, while forecasting a 4% growth in its earnings this year thanks in part to the Visa (V) decision to "allow dynamic currency conversion services on international ATM transactions globally."
03/21/19
DBAB
03/21/19
NO CHANGE
Target $177
DBAB
Buy
Visa price target raised to $177 from $160 at Deutsche Bank
Deutsche Bank analyst Bryan Keane raised his price target for Visa to $177 from $160 after meeting with management. The analyst sees Visa's growth troughing in Q2 and accelerating through the year. He feels comfortable that potential earnings upside remains in fiscal 2019 and reiterates a Buy rating on the shares.
03/25/19
JEFF
03/25/19
NO CHANGE
Target $175
JEFF
Buy
Visa price target raised to $175 from $170 at Jefferies
Jefferies analyst Michael Del Grosso raised his price target for Visa (V) to $175 from $170 after hosting investor meetings at the company's headquarters. Visa's "innovative capabilities" are underappreciated relative to MasterCard (MA) and its upcoming product roll-outs "may help close this perception gap," Del Grosso tells investors in a research note. He believes Visa's core growth story is intact and that new product capabilities "enhance the volume opportunity for the foreseeable future." The analyst reiterates a Buy rating on the shares.
MA MasterCard
$230.43

-0.34 (-0.15%)

02/19/19
BTIG
02/19/19
NO CHANGE
Target $114
BTIG
Buy
PayPal price target raised to $114 from $95 at BTIG
BTIG analyst Mark Palmer raised his price target on PayPal (PYPL) to $114 and kept his Buy rating, citing the company's "multi-faceted" growth story that includes accelerating active account additions, continued increases in customer engagement, and acceleration of Venmo payment volume. The analyst believes that PayPal can drive growth rates that are "about twice that of its peer group", justifying the premium of the stock relative to its peers. Palmer adds that PayPal shares still trade at a discount relative to MasterCard (MA) based on its enterprise value to expected FY21 EBITDA multiple.
03/14/19
WEDB
03/14/19
NO CHANGE
Target $235
WEDB
Outperform
MasterCard price target raised to $235 from $220 at Wedbush
Wedbush analyst Moshe Katri raised his price target for MasterCard to $235 from $220 as he likes the company's attractive business model, growth prospects and outlook for increasing shareholder returns. From a "big-picture" perspective, the analyst points to a host of growth/scale catalysts, including the disintermediation of cash/checks by electronic payments, networks' increased dominance in the payments' ecosystem, incremental revenue opportunities from European regulations, incremental catalysts from hyper-growth mobile payments, ACH-based revenue growth opportunities, increased traction in B2B, and potential revenue synergies from MasterCard's consulting practice. He reiterates an Outperform rating on the shares.
02/20/19
NOMU
02/20/19
NO CHANGE
Target $252
NOMU
Buy
MasterCard price target raised to $252 from $226 at Nomura Instinet
Nomura Instinet analyst Bill Carcache raised his price target for MasterCard to $252 after meeting with management and keeps a Buy rating on the shares.
GS Goldman Sachs
$188.52

-0.05 (-0.03%)

03/25/19
JEFF
03/25/19
NO CHANGE
JEFF
Jefferies downgrades Financials to Underweight on 'shocking' Fed meeting
Jefferies analyst Steven DeSanctis is "very surprised" by last week's Federal Reserve's decision taking rate hikes completely off table in 2019. The "shocking" Fed meeting means lower rates for longer, which is not good for Financials, DeSanctis tells investors in a research note. A "lack of catalysts and weaker earnings growth" going forward for the entire sector, not just banks, means an Underweight rating on the space makes sense, says the analyst. As such, he downgraded his rating on the Financial sector to Underweight from Market Weight. Publicly traded companies in the space include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC).
03/01/19
SBSH
03/01/19
NO CHANGE
SBSH
Neutral
Goldman Sachs faces 'tough legal setup' in 1MDB case, says Citi
Goldman Sachs' alleged role in the ongoing 1MDB scandal has weighed on the stock since November, Citi analyst Keith Horowitz tells investors in a research note. After researching the case and speaking with a subject matter expert, the analyst thinks Goldman "faces a tough legal setup" in the 1MDB case. He expects the company to settle with regulators and estimates a range of penalties from $1.5B to $9.0B, with a base case of $4B-$5B. He sees suspended business activities as unlikely. Despite the 14% underperformance since November, Goldman shares are fairly valued given continued 1MDB overhang, Horowitz tells investors in a research note. He keeps a Neutral rating on the shares.
02/21/19
02/21/19
INITIATION

Odeon's Dick Bove starts Goldman Sachs with Sell rating
Odeon analyst Dick Bove initiated coverage of Goldman Sachs with a Sell rating. Now is not the time to own the stock as indications are growing that Goldman's legal issues "are just beginning related to the events in Malaysia," Bove tells investors in a research note. The analyst adds that the Federal Reserve and U.S. Justice Department are also investigating these events and that fines are expected. Goldman Sachs in late morning trading is down $2.00 to $196.60.
02/01/19
02/01/19
DOWNGRADE

Sell
Societe Generale downgrades Goldman Sachs, Morgan Stanley to Sell
As previously reported, Societe Generale analyst Andrew Lim downgraded Goldman Sachs (GS) and Morgan Stanley (MS), both to Sell from Hold, citing his view that the credit cycle deterioration "has already been set in motion" and that it will pay to be defensive for the rest of 2019. Goldman and Morgan are much more exposed to pressure on market-sensitive revenues as purer investment banks, Lim tells investors. He does not have any Buy ratings on big U.S. banks, but continues to favor holding positions in Bank of America (BAC) and JP Morgan (JPM), which Lim views as the most defensive large cap U.S. banks, he tells investors.

TODAY'S FREE FLY STORIES

DE

Deere

$151.51

0.14 (0.09%)

21:31
06/16/19
06/16
21:31
06/16/19
21:31
Upgrade
Deere rating change  »

Deere upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 17

    Jul

TITN

Titan Machinery

$15.87

-0.6 (-3.64%)

, DE

Deere

$151.51

0.14 (0.09%)

21:30
06/16/19
06/16
21:30
06/16/19
21:30
Upgrade
Titan Machinery, Deere rating change  »

Titan Machinery upgraded…

TITN

Titan Machinery

$15.87

-0.6 (-3.64%)

DE

Deere

$151.51

0.14 (0.09%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 10

    Jul

  • 17

    Jul

  • 13

    Nov

CTTAY

Continental AG

$0.00

(0.00%)

21:26
06/16/19
06/16
21:26
06/16/19
21:26
Downgrade
Continental AG rating change  »

Continental AG downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

YARIY

Yara

$0.00

(0.00%)

20:50
06/16/19
06/16
20:50
06/16/19
20:50
Downgrade
Yara rating change  »

Yara downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTVA

Corteva

$25.20

0.23 (0.92%)

20:49
06/16/19
06/16
20:49
06/16/19
20:49
Upgrade
Corteva rating change at Deutsche Bank »

Corteva upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$125.30

0.45 (0.36%)

, SNE

Sony

$51.42

1.735 (3.49%)

19:15
06/16/19
06/16
19:15
06/16/19
19:15
Hot Stocks
Fly Intel: Top five weekend stock stories »

Catch up on the…

UTX

United Technologies

$125.30

0.45 (0.36%)

SNE

Sony

$51.42

1.735 (3.49%)

GRUB

GrubHub

$70.15

-2.76 (-3.79%)

AMZN

Amazon.com

$1,870.07

-0.23 (-0.01%)

GS

Goldman Sachs

$191.71

0.24 (0.13%)

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

BA

Boeing

$347.19

-1.54 (-0.44%)

RTN

Raytheon

$177.38

0.195 (0.11%)

MCK

McKesson

$133.19

-1.7 (-1.26%)

CAH

Cardinal Health

$44.16

-1.13 (-2.50%)

ABC

AmerisourceBergen

$85.01

-1.46 (-1.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 17

    Jun

  • 17

    Jun

  • 23

    Jun

  • 25

    Jun

  • 27

    Jun

  • 09

    Jul

  • 10

    Jul

  • 16

    Jul

GM

General Motors

$35.66

-0.36 (-1.00%)

18:49
06/16/19
06/16
18:49
06/16/19
18:49
Periodicals
GM won't deploy self-driving fleet until safer than human driver, Axios reports »

General Motors CEO Mary…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Aug

  • 12

    Aug

T

AT&T

$32.36

0.06 (0.19%)

, CMCSA

Comcast

$42.31

0.62 (1.49%)

17:58
06/16/19
06/16
17:58
06/16/19
17:58
On The Fly
Box Office Battle: 'Men in Black: International' wins weekend with just $28.5M »

Sony’s (SNE) "Men in…

T

AT&T

$32.36

0.06 (0.19%)

CMCSA

Comcast

$42.31

0.62 (1.49%)

CMCSK

Comcast

$0.00

(0.00%)

SNE

Sony

$51.42

1.735 (3.49%)

LGF.A

Lionsgate

$12.22

-0.85 (-6.50%)

DIS

Disney

$141.64

-0.09 (-0.06%)

VIAB

Viacom

$29.38

-0.28 (-0.94%)

VIA

Viacom

$34.61

0.14 (0.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 24

    Jul

  • 25

    Jul

  • 08

    Aug

  • 08

    Aug

GS

Goldman Sachs

$191.71

0.24 (0.13%)

17:43
06/16/19
06/16
17:43
06/16/19
17:43
Periodicals
Goldman Sachs combining private-investing units, WSJ reports »

Goldman Sachs is pulling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

DB

Deutsche Bank

$6.79

-0.07 (-1.02%)

17:38
06/16/19
06/16
17:38
06/16/19
17:38
Periodicals
Deutsche Bank to set up EUR50B bad bank, Financial Times reports »

Deutsche Bank is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$87.10

(0.00%)

16:35
06/16/19
06/16
16:35
06/16/19
16:35
Periodicals
Tires blow on United jet during Newark airport landing, Reuters reports »

Tires on a United…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$87.83

-0.48 (-0.54%)

16:33
06/16/19
06/16
16:33
06/16/19
16:33
Periodicals
Target registers back online after outage blamed on tech issue, Reuters says »

Target said its payment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INTC

Intel

$46.18

-0.54 (-1.16%)

16:30
06/16/19
06/16
16:30
06/16/19
16:30
Hot Stocks
Intel announces program for Israeli startups targeting tech inflections »

Intel announced a program…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 25

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:27
06/16/19
06/16
16:27
06/16/19
16:27
Periodicals
Boeing says will take time to rebuild customer confidence, Reuters reports »

The head of Boeing said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

GS

Goldman Sachs

$191.71

0.24 (0.13%)

16:19
06/16/19
06/16
16:19
06/16/19
16:19
Periodicals
Goldman Sachs skeptical of 'insurance' rate cuts from Fed, Reuters says »

Goldman Sachs economists…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

  • 16

    Jul

BA

Boeing

$347.19

-1.54 (-0.44%)

16:16
06/16/19
06/16
16:16
06/16/19
16:16
Periodicals
Trials nearing for Boeing 737 Max fix, WSJ reports »

The Federal Aviation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jun

  • 09

    Jul

ESLT

Elbit Systems

$154.55

0.55 (0.36%)

13:41
06/16/19
06/16
13:41
06/16/19
13:41
Hot Stocks
Elbit Systems awarded $50M contract »

Elbit Systems announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMGN

Amgen

$176.09

-0.74 (-0.42%)

13:40
06/16/19
06/16
13:40
06/16/19
13:40
Hot Stocks
Amgen announces BLINCYTO five-year overall survival data »

Amgen announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Sep

SILK

Silk Road Medical

$44.80

-0.95 (-2.08%)

13:35
06/16/19
06/16
13:35
06/16/19
13:35
Hot Stocks
Silk Road Medical announces final results for ROADSTER-2 study »

Silk Road Medical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Aug

  • 26

    Aug

EDIT

Editas Medicine

$21.72

-0.78 (-3.47%)

13:30
06/16/19
06/16
13:30
06/16/19
13:30
Hot Stocks
Editas presents pre-clinical data in Sickle Cell Disease, Beta-Thalassemia »

Editas Medicine announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNSS

Sunesis

$0.90

-0.055 (-5.79%)

13:28
06/16/19
06/16
13:28
06/16/19
13:28
Hot Stocks
Sunesis announces preliminary data from Phase 1b/2 trial of Vecabrutinib »

Sunesis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 25

    Jun

APLS

Apellis

$21.22

-0.14 (-0.66%)

13:23
06/16/19
06/16
13:23
06/16/19
13:23
Hot Stocks
Apellis presents data from ongoing Phase 2 PLAUDIT study of APL-2 »

Apellis Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jun

FTSV

Forty Seven

$10.55

-0.02 (-0.19%)

13:16
06/16/19
06/16
13:16
06/16/19
13:16
Hot Stocks
Forty Seven announces data from Phase 1b/2 trial of 5F9 in combo with Rituximab »

Forty Seven announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AZN

AstraZeneca

$39.68

-0.23 (-0.58%)

13:06
06/16/19
06/16
13:06
06/16/19
13:06
Hot Stocks
AstraZeneca announces results from interim analysis of Phase 2 ASCEND trial »

AstraZeneca announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

STRO

Sutro Biopharma

$11.17

-0.34 (-2.95%)

13:02
06/16/19
06/16
13:02
06/16/19
13:02
Hot Stocks
Sutro Biopharma announces interim Phase 1 safety data for STRO-001 »

Sutro Biopharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.